Search research articles
Contact Us
Filters
Showing results (21-30 of 83) with videos related to
Page
of 9
Sort By:
Studies in Health Technology and Informatics
|
September 14, 2004
A quantitative and qualitative evaluation of LISA, a decision support system for chemotherapy dosing in childhood acute lymphoblastic leukaemia
Jonathan Bury, Chris Hurt, Anindita Roy, et al.
Health Economics Review
|
December 31, 2019
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
Xingdi Hu, Kingsley P Wildman, Subham Basu, et al.
Pediatric Blood & Cancer
|
March 2, 2022
Surveillance and caregiver vaccination prevent varicella outbreaks in a residential care facility for children with cancer
Arpita Bhattacharyya, Anirban Das, Sonal Dalvi-Mitra, et al.
Pediatric Blood & Cancer
|
September 1, 2018
A triple-probe FISH screening strategy for risk-stratified therapy of acute lymphoblastic leukaemia in low-resource settings
Mayur Parihar, Manish K Singh, Rubina Islam, et al.
British Journal of Haematology
|
June 15, 2005
LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia
Jonathan Bury, Chris Hurt, Anindita Roy, et al.
Blood
|
November 26, 2010
Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity
Marc N Offman, Marcin Krol, Naina Patel, et al.
British Journal of Haematology
|
June 13, 2002
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells
Mark W Lowdell, Rose Craston, David Samuel, et al.
Haematologica
|
March 26, 2017
Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia
Owen J McGinn, Shekhar Krishnan, Jean-Pierre Bourquin, et al.
British Journal of Haematology
|
June 7, 2019
Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India
Prakriti Roy, Rubina Islam, Debparna Saha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia
Jan Zuna, Anthony M Ford, Martina Peham, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 83) with videos related to
Sort By:
Page
of 9
Studies in Health Technology and Informatics
|
September 14, 2004
A quantitative and qualitative evaluation of LISA, a decision support system for chemotherapy dosing in childhood acute lymphoblastic leukaemia
Jonathan Bury, Chris Hurt, Anindita Roy, et al.
Health Economics Review
|
December 31, 2019
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
Xingdi Hu, Kingsley P Wildman, Subham Basu, et al.
Pediatric Blood & Cancer
|
March 2, 2022
Surveillance and caregiver vaccination prevent varicella outbreaks in a residential care facility for children with cancer
Arpita Bhattacharyya, Anirban Das, Sonal Dalvi-Mitra, et al.
Pediatric Blood & Cancer
|
September 1, 2018
A triple-probe FISH screening strategy for risk-stratified therapy of acute lymphoblastic leukaemia in low-resource settings
Mayur Parihar, Manish K Singh, Rubina Islam, et al.
British Journal of Haematology
|
June 15, 2005
LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia
Jonathan Bury, Chris Hurt, Anindita Roy, et al.
Blood
|
November 26, 2010
Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity
Marc N Offman, Marcin Krol, Naina Patel, et al.
British Journal of Haematology
|
June 13, 2002
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells
Mark W Lowdell, Rose Craston, David Samuel, et al.
Haematologica
|
March 26, 2017
Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia
Owen J McGinn, Shekhar Krishnan, Jean-Pierre Bourquin, et al.
British Journal of Haematology
|
June 7, 2019
Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India
Prakriti Roy, Rubina Islam, Debparna Saha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia
Jan Zuna, Anthony M Ford, Martina Peham, et al.
Page
of 9